You are here: Industry Insights > Treatment

News List

Navigating the Neurodegenerative Crisis: A Multifaceted Approach Shruti Talashi
December 09, 2024
Overtaking more established issues like cancer and heart disease, neurological problems have become a major worldwide health concern.
Immunoconjugates: Biological Missiles for Diagnosis and Treatment Suzanne Elvidge
August 02, 2024
Immunoconjugates already play an important role in the treatment of cancer, and their role is likely to expand into other therapeutic indications.
Research Progress in the Treatment of Refractory Mycoplasma Pneumoniae Pneumonia Xiaomichong
June 25, 2024
Currently, the main clinical treatment methods for refractory Mycoplasma pneumoniae pneumonia (RMPP) after diagnosis include bronchoscope lavage, antibiotic therapy, glucocorticoid therapy, immune modulation treatment, antithrombotic therapy, and integrat
COPD Treatment Landscape David Orchard-Webb
January 19, 2024
The comprehensive management of Chronic Obstructive Pulmonary Disease (COPD) requires a multi-faceted approach encompassing medications, lifestyle adjustments, and surgical interventions.
Pharma and Biotech Review: Treatment Options for COVID-19: Decoding the Latest Developments Neeta Ratanghayra
March 11, 2020
The Coronavirus Disease 2019 (COVID-19), which emerged in Wuhan, a city of 11 million in Hubei province, has spread to more than two dozen countries, taking the lives of more than 2,800 people.
Postop Anxiety During Care Transitions Reduced With Peer Mentoring drugs.com
January 28, 2022
Mentoring programs can help improve patients' transition from hospital to home by reducing...
FDA Grants Emergency Use Authorization for Pfizer's Paxlovid Pill as First At-Home COVID-19 Treatment drugs
December 22, 2021
he U.S. Food and Drug Administration on Wednesday approved the emergency use of Pfizer's new antiviral pill Paxlovid in people who are at high risk for severe COVID-19. It's the first approved treatment for COVID-19 meant to be taken at home.
Evive Biotech meets primary and secondary endpoints in global Phase III clinical trial for their novel chemotherapy-induced neutropenia treatment prnasia
July 08, 2020
Evive Biotech, a global biologics company developing novel biological therapies, is delighted to announce that its pivotal Phase III study (NCT03252431) for F-627 (efbemalenograstim alpha) to treat chemotherapy-induced neutropenia (CIN) in breast cancer
Vice-premier stresses research on COVID-19 vaccine, treatment, medicine chinadaily
April 04, 2020
Vice-Premier Sun Chunlan on April 1 stressed making full use of the effective drugs and treatment technologies and accelerating the progress of vaccine research and development to fight the novel coronavirus disease (COVID-19).
FDA continues to facilitate development of COVID-19 treatments worldpharmanews
March 23, 2020
The U.S. Food and Drug Administration continues to play a critical role in the multifaceted all-of-government response to the COVID-19 pandemic.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 14 15 Next page